nodes	percent_of_prediction	percent_of_DWPC	metapath
Asenapine—ADRB1—type 1 diabetes mellitus	0.678	1	CbGaD
Asenapine—HTR7—umbilical artery—type 1 diabetes mellitus	0.0172	0.253	CbGeAlD
Asenapine—HTR2A—arteriole—type 1 diabetes mellitus	0.00615	0.0906	CbGeAlD
Asenapine—HTR7—autonomic nervous system—type 1 diabetes mellitus	0.00423	0.0622	CbGeAlD
Asenapine—DRD1—nerve—type 1 diabetes mellitus	0.00381	0.056	CbGeAlD
Asenapine—HTR7—peripheral nervous system—type 1 diabetes mellitus	0.00305	0.0449	CbGeAlD
Asenapine—HTR2A—autonomic nervous system—type 1 diabetes mellitus	0.00264	0.0388	CbGeAlD
Asenapine—UGT1A4—kidney—type 1 diabetes mellitus	0.00256	0.0376	CbGeAlD
Asenapine—HTR7—nerve—type 1 diabetes mellitus	0.00238	0.035	CbGeAlD
Asenapine—DRD2—nerve—type 1 diabetes mellitus	0.00225	0.0331	CbGeAlD
Asenapine—ADRA2A—peripheral nervous system—type 1 diabetes mellitus	0.00224	0.0329	CbGeAlD
Asenapine—HTR2A—peripheral nervous system—type 1 diabetes mellitus	0.0019	0.028	CbGeAlD
Asenapine—Liver injury—Ramipril—type 1 diabetes mellitus	0.00172	0.0491	CcSEcCtD
Asenapine—HRH2—cardiovascular system—type 1 diabetes mellitus	0.00164	0.0241	CbGeAlD
Asenapine—HTR2A—nerve—type 1 diabetes mellitus	0.00148	0.0218	CbGeAlD
Asenapine—Salivary hypersecretion—Ramipril—type 1 diabetes mellitus	0.0014	0.0402	CcSEcCtD
Asenapine—Gynaecomastia—Ramipril—type 1 diabetes mellitus	0.00129	0.037	CcSEcCtD
Asenapine—Anaphylactoid reaction—Ramipril—type 1 diabetes mellitus	0.00108	0.031	CcSEcCtD
Asenapine—HTR1B—cardiovascular system—type 1 diabetes mellitus	0.00108	0.0159	CbGeAlD
Asenapine—Hyponatraemia—Ramipril—type 1 diabetes mellitus	0.00105	0.0301	CcSEcCtD
Asenapine—HTR1D—cardiovascular system—type 1 diabetes mellitus	0.00105	0.0154	CbGeAlD
Asenapine—Loxapine—CHRM2—type 1 diabetes mellitus	0.00103	0.54	CrCbGaD
Asenapine—HTR1D—kidney—type 1 diabetes mellitus	0.00102	0.0151	CbGeAlD
Asenapine—ADRB1—cardiovascular system—type 1 diabetes mellitus	0.00102	0.015	CbGeAlD
Asenapine—HTR2B—cardiovascular system—type 1 diabetes mellitus	0.000973	0.0143	CbGeAlD
Asenapine—Orthostatic hypotension—Ramipril—type 1 diabetes mellitus	0.000959	0.0274	CcSEcCtD
Asenapine—Breast disorder—Ramipril—type 1 diabetes mellitus	0.000948	0.0271	CcSEcCtD
Asenapine—DRD2—retina—type 1 diabetes mellitus	0.000931	0.0137	CbGeAlD
Asenapine—Dysphagia—Ramipril—type 1 diabetes mellitus	0.000907	0.0259	CcSEcCtD
Asenapine—Loxapine—ADRB1—type 1 diabetes mellitus	0.000878	0.46	CrCbGaD
Asenapine—HTR1A—cardiovascular system—type 1 diabetes mellitus	0.000872	0.0128	CbGeAlD
Asenapine—Abdominal discomfort—Ramipril—type 1 diabetes mellitus	0.00087	0.0249	CcSEcCtD
Asenapine—ADRA2C—nephron tubule—type 1 diabetes mellitus	0.000852	0.0125	CbGeAlD
Asenapine—Neutropenia—Ramipril—type 1 diabetes mellitus	0.000848	0.0243	CcSEcCtD
Asenapine—ADRA2A—islet of Langerhans—type 1 diabetes mellitus	0.000845	0.0124	CbGeAlD
Asenapine—HTR7—cardiovascular system—type 1 diabetes mellitus	0.000833	0.0123	CbGeAlD
Asenapine—Weight increased—Ramipril—type 1 diabetes mellitus	0.000826	0.0236	CcSEcCtD
Asenapine—HTR7—kidney—type 1 diabetes mellitus	0.000815	0.012	CbGeAlD
Asenapine—ADRA1A—cardiovascular system—type 1 diabetes mellitus	0.000804	0.0118	CbGeAlD
Asenapine—Stomatitis—Ramipril—type 1 diabetes mellitus	0.000788	0.0225	CcSEcCtD
Asenapine—Hepatobiliary disease—Ramipril—type 1 diabetes mellitus	0.000765	0.0219	CcSEcCtD
Asenapine—Agranulocytosis—Ramipril—type 1 diabetes mellitus	0.000755	0.0216	CcSEcCtD
Asenapine—ADRA2C—kidney—type 1 diabetes mellitus	0.000749	0.011	CbGeAlD
Asenapine—ADRA2C—pancreas—type 1 diabetes mellitus	0.000744	0.011	CbGeAlD
Asenapine—Oedema peripheral—Ramipril—type 1 diabetes mellitus	0.000715	0.0205	CcSEcCtD
Asenapine—Connective tissue disorder—Ramipril—type 1 diabetes mellitus	0.000713	0.0204	CcSEcCtD
Asenapine—ADRA1A—lymphoid tissue—type 1 diabetes mellitus	0.000675	0.00994	CbGeAlD
Asenapine—Immune system disorder—Ramipril—type 1 diabetes mellitus	0.000656	0.0188	CcSEcCtD
Asenapine—Mediastinal disorder—Ramipril—type 1 diabetes mellitus	0.000654	0.0187	CcSEcCtD
Asenapine—Mental disorder—Ramipril—type 1 diabetes mellitus	0.000636	0.0182	CcSEcCtD
Asenapine—Malnutrition—Ramipril—type 1 diabetes mellitus	0.000632	0.0181	CcSEcCtD
Asenapine—Dysgeusia—Ramipril—type 1 diabetes mellitus	0.000619	0.0177	CcSEcCtD
Asenapine—HTR2A—retina—type 1 diabetes mellitus	0.000614	0.00904	CbGeAlD
Asenapine—Muscle spasms—Ramipril—type 1 diabetes mellitus	0.000608	0.0174	CcSEcCtD
Asenapine—ADRA2A—pancreas—type 1 diabetes mellitus	0.000594	0.00874	CbGeAlD
Asenapine—Tremor—Ramipril—type 1 diabetes mellitus	0.000592	0.0169	CcSEcCtD
Asenapine—Agitation—Ramipril—type 1 diabetes mellitus	0.000581	0.0166	CcSEcCtD
Asenapine—Angioedema—Ramipril—type 1 diabetes mellitus	0.000578	0.0165	CcSEcCtD
Asenapine—Malaise—Ramipril—type 1 diabetes mellitus	0.00057	0.0163	CcSEcCtD
Asenapine—Syncope—Ramipril—type 1 diabetes mellitus	0.000567	0.0162	CcSEcCtD
Asenapine—Leukopenia—Ramipril—type 1 diabetes mellitus	0.000566	0.0162	CcSEcCtD
Asenapine—Loss of consciousness—Ramipril—type 1 diabetes mellitus	0.000556	0.0159	CcSEcCtD
Asenapine—Convulsion—Ramipril—type 1 diabetes mellitus	0.000548	0.0157	CcSEcCtD
Asenapine—Arthralgia—Ramipril—type 1 diabetes mellitus	0.000538	0.0154	CcSEcCtD
Asenapine—Anxiety—Ramipril—type 1 diabetes mellitus	0.000536	0.0153	CcSEcCtD
Asenapine—Dry mouth—Ramipril—type 1 diabetes mellitus	0.000526	0.0151	CcSEcCtD
Asenapine—HTR2A—cardiovascular system—type 1 diabetes mellitus	0.000519	0.00765	CbGeAlD
Asenapine—Anaphylactic shock—Ramipril—type 1 diabetes mellitus	0.000516	0.0148	CcSEcCtD
Asenapine—HTR2A—kidney—type 1 diabetes mellitus	0.000508	0.00748	CbGeAlD
Asenapine—Shock—Ramipril—type 1 diabetes mellitus	0.000507	0.0145	CcSEcCtD
Asenapine—Nervous system disorder—Ramipril—type 1 diabetes mellitus	0.000506	0.0145	CcSEcCtD
Asenapine—Thrombocytopenia—Ramipril—type 1 diabetes mellitus	0.000505	0.0144	CcSEcCtD
Asenapine—Tachycardia—Ramipril—type 1 diabetes mellitus	0.000503	0.0144	CcSEcCtD
Asenapine—Hypotension—Ramipril—type 1 diabetes mellitus	0.000482	0.0138	CcSEcCtD
Asenapine—CYP3A4—kidney—type 1 diabetes mellitus	0.000471	0.00693	CbGeAlD
Asenapine—Musculoskeletal discomfort—Ramipril—type 1 diabetes mellitus	0.00047	0.0134	CcSEcCtD
Asenapine—Insomnia—Ramipril—type 1 diabetes mellitus	0.000467	0.0133	CcSEcCtD
Asenapine—CYP2D6—kidney—type 1 diabetes mellitus	0.000463	0.00682	CbGeAlD
Asenapine—Dyspnoea—Ramipril—type 1 diabetes mellitus	0.00046	0.0132	CcSEcCtD
Asenapine—Somnolence—Ramipril—type 1 diabetes mellitus	0.000459	0.0131	CcSEcCtD
Asenapine—Dyspepsia—Ramipril—type 1 diabetes mellitus	0.000454	0.013	CcSEcCtD
Asenapine—Gastrointestinal disorder—Ramipril—type 1 diabetes mellitus	0.000445	0.0127	CcSEcCtD
Asenapine—Fatigue—Ramipril—type 1 diabetes mellitus	0.000445	0.0127	CcSEcCtD
Asenapine—Constipation—Ramipril—type 1 diabetes mellitus	0.000441	0.0126	CcSEcCtD
Asenapine—Hypersensitivity—Ramipril—type 1 diabetes mellitus	0.00038	0.0109	CcSEcCtD
Asenapine—Asthenia—Ramipril—type 1 diabetes mellitus	0.00037	0.0106	CcSEcCtD
Asenapine—Dizziness—Ramipril—type 1 diabetes mellitus	0.000341	0.00976	CcSEcCtD
Asenapine—Vomiting—Ramipril—type 1 diabetes mellitus	0.000328	0.00938	CcSEcCtD
Asenapine—Rash—Ramipril—type 1 diabetes mellitus	0.000325	0.0093	CcSEcCtD
Asenapine—Dermatitis—Ramipril—type 1 diabetes mellitus	0.000325	0.00929	CcSEcCtD
Asenapine—Headache—Ramipril—type 1 diabetes mellitus	0.000323	0.00924	CcSEcCtD
Asenapine—Nausea—Ramipril—type 1 diabetes mellitus	0.000306	0.00876	CcSEcCtD
Asenapine—CYP1A2—Metabolism—GSTT1—type 1 diabetes mellitus	1.11e-05	5.13e-05	CbGpPWpGaD
Asenapine—ADRA2C—Metabolism—INS—type 1 diabetes mellitus	1.11e-05	5.12e-05	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—TYK2—type 1 diabetes mellitus	1.11e-05	5.11e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—KCNJ11—type 1 diabetes mellitus	1.11e-05	5.11e-05	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—NOS3—type 1 diabetes mellitus	1.11e-05	5.1e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—ERBB3—type 1 diabetes mellitus	1.1e-05	5.08e-05	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—INS—type 1 diabetes mellitus	1.1e-05	5.08e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—CD86—type 1 diabetes mellitus	1.1e-05	5.05e-05	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—NOS3—type 1 diabetes mellitus	1.09e-05	5.01e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—ERBB3—type 1 diabetes mellitus	1.09e-05	5e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—CCR5—type 1 diabetes mellitus	1.09e-05	5e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—ERBB3—type 1 diabetes mellitus	1.08e-05	4.99e-05	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—IGF1—type 1 diabetes mellitus	1.08e-05	4.98e-05	CbGpPWpGaD
Asenapine—HTR1E—Signaling Pathways—EGFR—type 1 diabetes mellitus	1.08e-05	4.98e-05	CbGpPWpGaD
Asenapine—DRD1—Signaling by GPCR—EGFR—type 1 diabetes mellitus	1.08e-05	4.95e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—IL2RA—type 1 diabetes mellitus	1.07e-05	4.93e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—CCR5—type 1 diabetes mellitus	1.07e-05	4.92e-05	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—IGF1—type 1 diabetes mellitus	1.07e-05	4.91e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—CCR5—type 1 diabetes mellitus	1.07e-05	4.91e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—ERBB3—type 1 diabetes mellitus	1.06e-05	4.9e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—CD80—type 1 diabetes mellitus	1.06e-05	4.9e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling by GPCR—IL2—type 1 diabetes mellitus	1.06e-05	4.89e-05	CbGpPWpGaD
Asenapine—DRD3—Signaling by GPCR—EGFR—type 1 diabetes mellitus	1.06e-05	4.89e-05	CbGpPWpGaD
Asenapine—HRH2—Signaling Pathways—STAT3—type 1 diabetes mellitus	1.06e-05	4.88e-05	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—TYK2—type 1 diabetes mellitus	1.06e-05	4.88e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—CD80—type 1 diabetes mellitus	1.05e-05	4.85e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—IL2RA—type 1 diabetes mellitus	1.05e-05	4.85e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—IL2RA—type 1 diabetes mellitus	1.05e-05	4.84e-05	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—GCG—type 1 diabetes mellitus	1.05e-05	4.82e-05	CbGpPWpGaD
Asenapine—ADRA2A—GPCR downstream signaling—IL2—type 1 diabetes mellitus	1.05e-05	4.82e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—CCR5—type 1 diabetes mellitus	1.05e-05	4.82e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling by GPCR—IL2—type 1 diabetes mellitus	1.05e-05	4.81e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling by GPCR—IL2—type 1 diabetes mellitus	1.04e-05	4.8e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—CD80—type 1 diabetes mellitus	1.04e-05	4.79e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—E2F1—type 1 diabetes mellitus	1.04e-05	4.79e-05	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—NOS3—type 1 diabetes mellitus	1.04e-05	4.79e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—IL2RA—type 1 diabetes mellitus	1.03e-05	4.75e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	1.03e-05	4.73e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling by GPCR—IL2—type 1 diabetes mellitus	1.02e-05	4.71e-05	CbGpPWpGaD
Asenapine—ADRA2C—Metabolism—ALB—type 1 diabetes mellitus	1.02e-05	4.7e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—CD80—type 1 diabetes mellitus	1.02e-05	4.68e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—CD80—type 1 diabetes mellitus	1.01e-05	4.66e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—INS—type 1 diabetes mellitus	1e-05	4.63e-05	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—TYK2—type 1 diabetes mellitus	9.99e-06	4.6e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—INS—type 1 diabetes mellitus	9.96e-06	4.59e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—ERBB3—type 1 diabetes mellitus	9.88e-06	4.55e-05	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—TYK2—type 1 diabetes mellitus	9.85e-06	4.54e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—CD80—type 1 diabetes mellitus	9.84e-06	4.53e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—INS—type 1 diabetes mellitus	9.83e-06	4.53e-05	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—NOS3—type 1 diabetes mellitus	9.8e-06	4.51e-05	CbGpPWpGaD
Asenapine—ADRA2C—Metabolism—NOS3—type 1 diabetes mellitus	9.76e-06	4.49e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—CCR5—type 1 diabetes mellitus	9.72e-06	4.48e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—IGF1—type 1 diabetes mellitus	9.72e-06	4.48e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling by GPCR—EGFR—type 1 diabetes mellitus	9.67e-06	4.45e-05	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—NOS3—type 1 diabetes mellitus	9.67e-06	4.45e-05	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—CASP3—type 1 diabetes mellitus	9.67e-06	4.45e-05	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—CASP3—type 1 diabetes mellitus	9.66e-06	4.45e-05	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—IL2—type 1 diabetes mellitus	9.65e-06	4.45e-05	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—IL2—type 1 diabetes mellitus	9.64e-06	4.44e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—IGF1—type 1 diabetes mellitus	9.63e-06	4.43e-05	CbGpPWpGaD
Asenapine—HRH2—Signaling Pathways—EGFR—type 1 diabetes mellitus	9.63e-06	4.43e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—INS—type 1 diabetes mellitus	9.61e-06	4.43e-05	CbGpPWpGaD
Asenapine—HTR6—Signaling by GPCR—IL6—type 1 diabetes mellitus	9.61e-06	4.42e-05	CbGpPWpGaD
Asenapine—HTR7—Signaling by GPCR—IL6—type 1 diabetes mellitus	9.6e-06	4.42e-05	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—CASP3—type 1 diabetes mellitus	9.59e-06	4.42e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling by GPCR—EGFR—type 1 diabetes mellitus	9.58e-06	4.41e-05	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—IL2—type 1 diabetes mellitus	9.58e-06	4.41e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—IL2RA—type 1 diabetes mellitus	9.58e-06	4.41e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—INS—type 1 diabetes mellitus	9.56e-06	4.4e-05	CbGpPWpGaD
Asenapine—HTR1D—Signaling by GPCR—IL6—type 1 diabetes mellitus	9.53e-06	4.39e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—IGF1—type 1 diabetes mellitus	9.51e-06	4.38e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling by GPCR—IL2—type 1 diabetes mellitus	9.51e-06	4.38e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling by GPCR—EGFR—type 1 diabetes mellitus	9.46e-06	4.36e-05	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—CASP3—type 1 diabetes mellitus	9.39e-06	4.33e-05	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—IL2—type 1 diabetes mellitus	9.38e-06	4.32e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—ITPR3—type 1 diabetes mellitus	9.36e-06	4.31e-05	CbGpPWpGaD
Asenapine—HTR1B—Signaling by GPCR—IL6—type 1 diabetes mellitus	9.33e-06	4.3e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—INS—type 1 diabetes mellitus	9.3e-06	4.28e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—IGF1—type 1 diabetes mellitus	9.3e-06	4.28e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling by GPCR—EGFR—type 1 diabetes mellitus	9.25e-06	4.26e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—IGF1—type 1 diabetes mellitus	9.25e-06	4.26e-05	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—CASP3—type 1 diabetes mellitus	9.25e-06	4.26e-05	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—IL2—type 1 diabetes mellitus	9.23e-06	4.25e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling by GPCR—EGFR—type 1 diabetes mellitus	9.2e-06	4.24e-05	CbGpPWpGaD
Asenapine—DRD4—Signaling by GPCR—IL6—type 1 diabetes mellitus	9.19e-06	4.23e-05	CbGpPWpGaD
Asenapine—ADRA2A—Metabolism—INS—type 1 diabetes mellitus	9.04e-06	4.16e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—IGF1—type 1 diabetes mellitus	9e-06	4.14e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—TYK2—type 1 diabetes mellitus	8.98e-06	4.13e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling by GPCR—EGFR—type 1 diabetes mellitus	8.95e-06	4.12e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—CD80—type 1 diabetes mellitus	8.93e-06	4.11e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—TYK2—type 1 diabetes mellitus	8.9e-06	4.1e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—GCG—type 1 diabetes mellitus	8.88e-06	4.09e-05	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—CAT—type 1 diabetes mellitus	8.87e-06	4.08e-05	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—CASP3—type 1 diabetes mellitus	8.83e-06	4.06e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—NOS3—type 1 diabetes mellitus	8.81e-06	4.06e-05	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—IL2—type 1 diabetes mellitus	8.81e-06	4.06e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—HBA1—type 1 diabetes mellitus	8.81e-06	4.06e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—CD80—type 1 diabetes mellitus	8.79e-06	4.05e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—TYK2—type 1 diabetes mellitus	8.78e-06	4.04e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—CD80—type 1 diabetes mellitus	8.77e-06	4.04e-05	CbGpPWpGaD
Asenapine—HTR2B—Signaling by GPCR—IL6—type 1 diabetes mellitus	8.77e-06	4.04e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—APOC3—type 1 diabetes mellitus	8.75e-06	4.03e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—NOS3—type 1 diabetes mellitus	8.73e-06	4.02e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—NOS3—type 1 diabetes mellitus	8.62e-06	3.97e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—CD80—type 1 diabetes mellitus	8.61e-06	3.96e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—GSTT1—type 1 diabetes mellitus	8.6e-06	3.96e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—TYK2—type 1 diabetes mellitus	8.59e-06	3.95e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—TYK2—type 1 diabetes mellitus	8.54e-06	3.93e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—INS—type 1 diabetes mellitus	8.44e-06	3.89e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—NOS3—type 1 diabetes mellitus	8.43e-06	3.88e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—NOS3—type 1 diabetes mellitus	8.39e-06	3.86e-05	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—CASP3—type 1 diabetes mellitus	8.32e-06	3.83e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—TYK2—type 1 diabetes mellitus	8.31e-06	3.83e-05	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—IL2—type 1 diabetes mellitus	8.31e-06	3.83e-05	CbGpPWpGaD
Asenapine—HTR1E—Signaling Pathways—IL6—type 1 diabetes mellitus	8.31e-06	3.82e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—INS—type 1 diabetes mellitus	8.3e-06	3.82e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—INS—type 1 diabetes mellitus	8.29e-06	3.82e-05	CbGpPWpGaD
Asenapine—ADRA2A—Metabolism—ALB—type 1 diabetes mellitus	8.28e-06	3.81e-05	CbGpPWpGaD
Asenapine—DRD1—Signaling by GPCR—IL6—type 1 diabetes mellitus	8.27e-06	3.81e-05	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—CASP3—type 1 diabetes mellitus	8.21e-06	3.78e-05	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—IL2—type 1 diabetes mellitus	8.2e-06	3.78e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—IGF1—type 1 diabetes mellitus	8.16e-06	3.76e-05	CbGpPWpGaD
Asenapine—DRD3—Signaling by GPCR—IL6—type 1 diabetes mellitus	8.16e-06	3.76e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—NOS3—type 1 diabetes mellitus	8.16e-06	3.76e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—INS—type 1 diabetes mellitus	8.13e-06	3.74e-05	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—STAT3—type 1 diabetes mellitus	8.12e-06	3.74e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling by GPCR—EGFR—type 1 diabetes mellitus	8.12e-06	3.74e-05	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—STAT3—type 1 diabetes mellitus	8.11e-06	3.74e-05	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—STAT3—type 1 diabetes mellitus	8.06e-06	3.71e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—IGF1—type 1 diabetes mellitus	8.03e-06	3.7e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—IGF1—type 1 diabetes mellitus	8.02e-06	3.69e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—CD80—type 1 diabetes mellitus	8e-06	3.68e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling by GPCR—EGFR—type 1 diabetes mellitus	7.99e-06	3.68e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling by GPCR—EGFR—type 1 diabetes mellitus	7.98e-06	3.67e-05	CbGpPWpGaD
Asenapine—ADRA2A—Metabolism—NOS3—type 1 diabetes mellitus	7.92e-06	3.65e-05	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—STAT3—type 1 diabetes mellitus	7.89e-06	3.63e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—IGF1—type 1 diabetes mellitus	7.87e-06	3.62e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling by GPCR—EGFR—type 1 diabetes mellitus	7.83e-06	3.6e-05	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—STAT3—type 1 diabetes mellitus	7.77e-06	3.58e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—INS—type 1 diabetes mellitus	7.56e-06	3.48e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—TYK2—type 1 diabetes mellitus	7.54e-06	3.47e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—CAT—type 1 diabetes mellitus	7.51e-06	3.46e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—CASP3—type 1 diabetes mellitus	7.48e-06	3.45e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—IL2—type 1 diabetes mellitus	7.47e-06	3.44e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling by GPCR—IL6—type 1 diabetes mellitus	7.43e-06	3.42e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—TYK2—type 1 diabetes mellitus	7.42e-06	3.42e-05	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—STAT3—type 1 diabetes mellitus	7.42e-06	3.41e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—CASP3—type 1 diabetes mellitus	7.41e-06	3.41e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—TYK2—type 1 diabetes mellitus	7.4e-06	3.41e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—IL2—type 1 diabetes mellitus	7.4e-06	3.41e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—NOS3—type 1 diabetes mellitus	7.4e-06	3.41e-05	CbGpPWpGaD
Asenapine—HRH2—Signaling Pathways—IL6—type 1 diabetes mellitus	7.4e-06	3.41e-05	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—EGFR—type 1 diabetes mellitus	7.38e-06	3.4e-05	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—EGFR—type 1 diabetes mellitus	7.38e-06	3.4e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling by GPCR—IL6—type 1 diabetes mellitus	7.37e-06	3.39e-05	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—EGFR—type 1 diabetes mellitus	7.33e-06	3.37e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—CASP3—type 1 diabetes mellitus	7.32e-06	3.37e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—IL2—type 1 diabetes mellitus	7.31e-06	3.37e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—IGF1—type 1 diabetes mellitus	7.31e-06	3.36e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—NOS3—type 1 diabetes mellitus	7.28e-06	3.35e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling by GPCR—IL6—type 1 diabetes mellitus	7.27e-06	3.35e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling by GPCR—EGFR—type 1 diabetes mellitus	7.27e-06	3.35e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—NOS3—type 1 diabetes mellitus	7.27e-06	3.35e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—TYK2—type 1 diabetes mellitus	7.26e-06	3.35e-05	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—EGFR—type 1 diabetes mellitus	7.17e-06	3.3e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—CASP3—type 1 diabetes mellitus	7.16e-06	3.3e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—IL2—type 1 diabetes mellitus	7.15e-06	3.29e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—NOS3—type 1 diabetes mellitus	7.13e-06	3.28e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—CASP3—type 1 diabetes mellitus	7.12e-06	3.28e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling by GPCR—IL6—type 1 diabetes mellitus	7.11e-06	3.27e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—IL2—type 1 diabetes mellitus	7.11e-06	3.27e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling by GPCR—IL6—type 1 diabetes mellitus	7.07e-06	3.26e-05	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—EGFR—type 1 diabetes mellitus	7.06e-06	3.25e-05	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—STAT3—type 1 diabetes mellitus	6.99e-06	3.22e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—CASP3—type 1 diabetes mellitus	6.93e-06	3.19e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—IL2—type 1 diabetes mellitus	6.91e-06	3.18e-05	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—STAT3—type 1 diabetes mellitus	6.9e-06	3.18e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling by GPCR—IL6—type 1 diabetes mellitus	6.88e-06	3.17e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—GCG—type 1 diabetes mellitus	6.85e-06	3.15e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—TYK2—type 1 diabetes mellitus	6.75e-06	3.11e-05	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—EGFR—type 1 diabetes mellitus	6.74e-06	3.1e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—NOS3—type 1 diabetes mellitus	6.63e-06	3.05e-05	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—EGFR—type 1 diabetes mellitus	6.36e-06	2.93e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—STAT3—type 1 diabetes mellitus	6.29e-06	2.89e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—CASP3—type 1 diabetes mellitus	6.28e-06	2.89e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—IL2—type 1 diabetes mellitus	6.27e-06	2.89e-05	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—EGFR—type 1 diabetes mellitus	6.27e-06	2.89e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling by GPCR—IL6—type 1 diabetes mellitus	6.24e-06	2.87e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—STAT3—type 1 diabetes mellitus	6.23e-06	2.87e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—CASP3—type 1 diabetes mellitus	6.18e-06	2.85e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—IL2—type 1 diabetes mellitus	6.17e-06	2.84e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—CASP3—type 1 diabetes mellitus	6.17e-06	2.84e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—IL2—type 1 diabetes mellitus	6.16e-06	2.84e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—STAT3—type 1 diabetes mellitus	6.15e-06	2.83e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling by GPCR—IL6—type 1 diabetes mellitus	6.14e-06	2.83e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling by GPCR—IL6—type 1 diabetes mellitus	6.13e-06	2.82e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—CASP3—type 1 diabetes mellitus	6.05e-06	2.79e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—IL2—type 1 diabetes mellitus	6.04e-06	2.78e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling by GPCR—IL6—type 1 diabetes mellitus	6.01e-06	2.77e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—STAT3—type 1 diabetes mellitus	6.01e-06	2.77e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—STAT3—type 1 diabetes mellitus	5.98e-06	2.75e-05	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—INS—type 1 diabetes mellitus	5.89e-06	2.71e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—STAT3—type 1 diabetes mellitus	5.82e-06	2.68e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—CAT—type 1 diabetes mellitus	5.8e-06	2.67e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—EGFR—type 1 diabetes mellitus	5.71e-06	2.63e-05	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—IL6—type 1 diabetes mellitus	5.67e-06	2.61e-05	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—IL6—type 1 diabetes mellitus	5.67e-06	2.61e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—EGFR—type 1 diabetes mellitus	5.66e-06	2.61e-05	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—IL6—type 1 diabetes mellitus	5.63e-06	2.59e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—CASP3—type 1 diabetes mellitus	5.63e-06	2.59e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—IL2—type 1 diabetes mellitus	5.62e-06	2.59e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—EGFR—type 1 diabetes mellitus	5.59e-06	2.57e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling by GPCR—IL6—type 1 diabetes mellitus	5.59e-06	2.57e-05	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—IL6—type 1 diabetes mellitus	5.51e-06	2.54e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—EGFR—type 1 diabetes mellitus	5.47e-06	2.52e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—EGFR—type 1 diabetes mellitus	5.44e-06	2.5e-05	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—IL6—type 1 diabetes mellitus	5.43e-06	2.5e-05	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—ALB—type 1 diabetes mellitus	5.4e-06	2.49e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—EGFR—type 1 diabetes mellitus	5.29e-06	2.44e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—STAT3—type 1 diabetes mellitus	5.28e-06	2.43e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—STAT3—type 1 diabetes mellitus	5.2e-06	2.39e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—STAT3—type 1 diabetes mellitus	5.18e-06	2.39e-05	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—IL6—type 1 diabetes mellitus	5.18e-06	2.38e-05	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—NOS3—type 1 diabetes mellitus	5.16e-06	2.38e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—STAT3—type 1 diabetes mellitus	5.09e-06	2.34e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—INS—type 1 diabetes mellitus	4.99e-06	2.3e-05	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—IL6—type 1 diabetes mellitus	4.88e-06	2.25e-05	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—IL6—type 1 diabetes mellitus	4.82e-06	2.22e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—EGFR—type 1 diabetes mellitus	4.8e-06	2.21e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—STAT3—type 1 diabetes mellitus	4.73e-06	2.18e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—EGFR—type 1 diabetes mellitus	4.72e-06	2.17e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—EGFR—type 1 diabetes mellitus	4.71e-06	2.17e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—EGFR—type 1 diabetes mellitus	4.62e-06	2.13e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—ALB—type 1 diabetes mellitus	4.57e-06	2.11e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—IL6—type 1 diabetes mellitus	4.39e-06	2.02e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—NOS3—type 1 diabetes mellitus	4.37e-06	2.01e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—IL6—type 1 diabetes mellitus	4.35e-06	2e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—IL6—type 1 diabetes mellitus	4.3e-06	1.98e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—EGFR—type 1 diabetes mellitus	4.3e-06	1.98e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—IL6—type 1 diabetes mellitus	4.2e-06	1.93e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—IL6—type 1 diabetes mellitus	4.18e-06	1.92e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—IL6—type 1 diabetes mellitus	4.06e-06	1.87e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—INS—type 1 diabetes mellitus	3.85e-06	1.77e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—IL6—type 1 diabetes mellitus	3.69e-06	1.7e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—IL6—type 1 diabetes mellitus	3.63e-06	1.67e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—IL6—type 1 diabetes mellitus	3.62e-06	1.67e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—IL6—type 1 diabetes mellitus	3.55e-06	1.64e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—ALB—type 1 diabetes mellitus	3.53e-06	1.62e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—NOS3—type 1 diabetes mellitus	3.38e-06	1.55e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—IL6—type 1 diabetes mellitus	3.3e-06	1.52e-05	CbGpPWpGaD
